Wanbury Ltd share price logo

Wanbury Ltd

NSE: WANBURY

BSE: 524212

Small Cap

Pharma Sector

₹283.45

+0.45

(+0.16%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Wanbury Stock Performance

as on May 22, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹268.85
    ₹290.00
    downward going graph

    5.15%

    Downside

    2.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹161.50
    ₹329.70
    downward going graph

    43.02%

    Downside

    16.32%

    Upside

    downward going graph

Wanbury share price movements today

Previous Close
₹283.00
Open
₹284.20
Volume
80.54K
Upper Circuit
₹297.15
Lower Circuit
₹268.85
Day's Low - High
₹268.85 - ₹290.00
52 Week Low - High
₹161.50 - ₹329.70

Wanbury Historical Returns

1 Month Return
+ 4.94 %
3 Month Return
+ 4.12 %
1 Year Return
-2.6 %
3 Year Return
+ 504.7 %
5 Year Return
+ 171.98 %

Wanbury Fundamentals

as on May 22, 2026 at 4:01 pm IST

Market Cap

₹988.78 Cr

Return on Equity (ROE)

18.3

PE Ratio (TTM)

21.57

Return on capital employed (ROCE)

19.97

Industry PE ratio

46.14

Beta (LTM)

1.19

P/B Ratio

14.43

Dividend Yield

0

PEG Ratio

-7.52

Quarterly Earnings Growth YOY

1197.12

EPS (TTM)

9.32

Sector

Pharmaceuticals

Book Value

16.26

Wanbury Stock Valuation

as on May 22, 2026 at 4:01 pm IST

Wanbury in the last 5 years

  • Overview

  • Trends

Lowest (-105.12x)

July 15, 2021

Today (21.57x)

May 21, 2026

Industry (46.14x)

May 21, 2026

Highest (146.91x)

September 29, 2023

LowHigh

Today’s Price to Earnings Ratio: 21.57x

Wanbury Technical Analysis

Track how Wanbury technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish3
Bullish8
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
-0.42
Bullish
CCI (20)
-88.54
Neutral
RSI (14)
53.36
Neutral
Momentum (10)
-0.95
Bullish
ADI (14)
22.24
Neutral
Ultimate Oscillator (7,14,28)
62.13
Neutral

Moving Averages

Name

Value

Action

SMA (20)
283.02
Bullish
EMA (20)
283.09
Bullish
VWMA (20)
282.96
Bullish
SMA (50)
284.24
Bearish
EMA (50)
283.71
Bullish
SMA (200)
282.6
Bullish
EMA (200)
282.69
Bullish
KAMA (200)
284.29
Bearish
DEMA (200)
284.29
Bearish

Wanbury Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Wanbury with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Wanbury Ltd image
Wanbury Ltd
NA988.7834.4%0.8830599
Brawn Biotech Ltd image
Brawn Biotech Ltd
NA6.48-7.44%0.00-213
Par Drugs & Chemicals Ltd image
Par Drugs & Chemicals Ltd
NA102.464.17%0.0013100
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,320.641526.67%0.00932
Bajaj Healthcare Ltd image
Bajaj Healthcare Ltd
NA1,024.86-3.22%0.0039542
See all

Wanbury Stock’s Investor Sentiment and Interest

Search interest for Wanbury Ltd Stock has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:45% versus previous 30 day period

Wanbury Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
146.29
144.46
145.5
139.41
131.11
161.19
133.45
172
163.18
Other Income
0.62
0.76
0.69
26.48
0.94
1.63
0.84
1.84
0.35
Total Income
146.9
145.22
146.19
165.89
132.05
162.82
134.29
173.84
163.53
Expenses
132.94
127.12
124.35
121.24
120.13
141.18
119.51
142.37
138.74
Operating Profit
13.35
17.34
21.15
18.17
10.98
20.01
13.94
29.63
24.44
Operating Profit Margin %
9.13%
12%
14.54%
13.03%
8.37%
12.41%
10.45%
17.23%
14.98%
Profit Before Interest, Tax and Depreciation
13.96
18.1
21.84
44.65
11.92
21.64
14.78
31.47
24.79
Interest
5.79
7.67
8.26
7.46
7.59
10.15
10.17
9.04
7.54
Depreciation
3.18
3.24
3.32
3.28
3.29
3.32
3.32
3.37
3.64
Profit Before Tax
4.99
7.19
10.26
33.91
1.04
8.17
1.29
19.06
13.61
Tax Paid
0.3
-0.18
-0.02
0.27
-
0.15
0.07
-1.2
0.12
Profit After Tax
4.69
7.36
10.27
33.63
1.04
8.02
1.22
20.26
13.49
Total Net profit including share of profit / Loss from associate company
4.69
7.36
10.27
33.63
1.04
8.02
1.22
20.26
13.49
EPS
1.43
2.25
3.14
10.28
0.32
2.44
0.38
6.18
4.12
Actual EPS
1.43
2.25
3.14
10.28
0.32
2.44
0.38
6.18
4.12
Adjusted EPS
1.43
2.25
3.14
10.28
0.32
2.44
0.38
6.18
4.12
Diluted EPS
1.43
2.25
3.13
10.08
0.31
2.34
0.35
5.98
3.95

Wanbury Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
374.17
391.37
367.45
392.52
511.19
499.65
575.65
599.51
Other Income
76.14
9.33
83.78
2.4
77.88
0.91
28.55
3.49
Total Income
450.31
400.7
451.23
394.92
589.06
500.56
604.2
603.01
Expenses
441.66
375.83
344.01
374.5
475.87
477.07
505.65
523.2
Operating Profit
-67.49
15.54
23.44
18.02
35.32
22.58
70
76.31
Operating Profit Margin %
-18.04%
3.97%
6.38%
4.59%
6.91%
4.52%
12.16%
12.73%
Profit Before Interest, Tax and Depreciation
8.66
24.87
107.23
20.42
113.19
23.49
98.55
79.81
Interest
30.74
39.88
32.87
23.07
20.61
21.39
29.18
36.95
Depreciation
10.3
9.97
9.68
9.75
11.45
12.38
13.03
13.31
Profit Before Tax
-32.38
-24.98
64.68
-12.4
81.13
-10.28
56.34
29.55
Tax Paid
-0.38
-0.14
0.21
0.2
-0.35
0.11
0.38
-0.98
Profit After Tax
-32.01
-24.85
64.46
-12.61
81.47
-10.4
55.96
30.53
Total Net profit including share of profit / Loss from associate company
-32.01
-24.85
64.46
-12.61
81.47
-10.4
55.96
30.53
EPS
-13.49
-10.48
26.9
-5.04
25.29
-3.18
17.1
9.32
Actual EPS
-13.49
-10.48
26.9
-5.04
25.29
-3.18
17.1
9.32
Adjusted EPS
-13.49
-10.48
26.9
-5.04
25.29
-3.18
17.1
9.32
Diluted EPS
-13.49
-10.48
26.9
-5.04
25.21
-3.18
16.89
8.98

Wanbury Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
43.05
43.39
32.49
29.73
44.13
16.68
40.52
19.8
4.7
26.1
Cash Flow from Investing Activities
1.58
1.64
1.46
1.64
71.49
12.47
10.25
3.79
0.8
-2.14
Cash Flow from Financing Activities
-28.08
-26.94
-33.26
-26.78
-107.87
-17.39
-28.59
-31.99
13.87
25.74
Net Cash Flow
-4.65
3.39
-2.16
-0.13
-0.08
7.34
12.52
-21.03
1.94
0.66

Mutual Funds that own Wanbury Stock

Check out the Mutual Funds with significant holdings in Wanbury.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.04%
248

Wanbury Corporate Actions

View detailed summary of the earnings and dividend history of Wanbury.

  • Wanbury Ltd Earnings Results

    Wanbury Ltd’s net profit jumped 1197.12% since last year same period to ₹13.49Cr in the Q1 2025-2026. On a quarterly growth basis, Wanbury Ltd has generated -33.42% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Wanbury Ltd Dividends May,2010

    In the quarter ending March 2010, Wanbury Ltd has declared dividend of ₹1.00 per share on 28 May 2010 - translating a dividend yield of 0.35%.

    Read More about Dividends

Indices Featuring Wanbury Stock

Check stock indices that include Wanbury.

BSE Healthcare

₹47,267.53

-1.23 (▲589.53%)

Insights on Wanbury Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 56.21% to 56.39% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, WANBURY stock has moved up by 10.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.1% return, outperforming this stock by 41.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.72% to 0.59% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 20.26 Cr → 13.49 Cr (in ₹), with an average decrease of 33.4% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 43.07% to 43.02% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 173.84 Cr → 163.53 Cr (in ₹), with an average decrease of 5.9% per quarter

About Wanbury Ltd

Wanbury Ltd Formerly known Pearl Organics Limited was incorporated in August 1988. The Company is engaged in the business of pharmaceutical and related activities including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995 the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996 it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 200708 the merger of Doctors Organic Chemicals Limited DOCL with the Company became effective from 1st April 2007. Pursuant to the aforesaid Order of the Honble Bl FR 785557 Equity Shares of face value of Rs. 10/ each of the Company were issued to the Equity Shareholders of DOCL on 17th March 2008. Similarly the Pharmaceutical Products of India Limited PPIL was merged with the Company effective from April 1 2006. In terms of the said Scheme of Merger the Company had issued 562618 Equity Shares of face value of Rs. 10/ each to the Equity Shareholders of PPIL on 27 June 2007 which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in ZurichSwitzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.The novel product Cdense Gems was launched in May 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched MyotolF targeted at female infertility in 2013 it launched Folinine. The Companys newly launched products MyotolF to treat polycystic ovarian syndrome and CalK2 in prevention and management of Osteoporosis were labelled as one of the best launches in 2014..

Revenue: ₹163.18Cr as on June 2025 (Q1 FY26)
Net Profit: ₹13.49Cr as on June 2025 (Q1 FY26)
Listing date: 29 Jan, 2007
Chairperson Name: K Chandran
OrganisationWanbury Ltd
IndustryPharmaceuticals
CEOK Chandran
E-voting on sharesClick here to vote

FAQs

What is Wanbury share price today?

Wanbury share price today stands at ₹283.45 as on at the close of the market. Wanbury share today touched a day high of ₹290 and a low of ₹268.85.

What is the 52 week high and 52 week low range for Wanbury share?

Wanbury touched a 52 week high of ₹329.7 and a 52 week low of ₹161.5. Wanbury share price today i.e. is closed at ₹283.45, which is -14.03% down from its 52 week high and 75.51% up from its 52 week low.

What is Wanbury's market capitalisation today?

Wanbury market capitalisation is ₹988.78 Cr as on .

How to buy Wanbury shares?

To buy Wanbury shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for WANBURY or Wanbury Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Wanbury shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Wanbury trading volume today?

Wanbury trading volume is 80.54K as on . This means that 80.54K shares of Wanbury were bought and sold on the stock market during today's trading session.